NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 14, 2022 Bearish $8.70 X 0
Dec 16, 2021 Bullish $9.02 V 0
Dec 15, 2021 Bearish $9.02 X 0
Nov 8, 2021 Bullish $12.57 X 0
JS JS Pro
Jun 29, 2021 $15.83 +1.41% $15.61 X 98.59% 2
Jun 29, 2021 Bullish $15.61 X 0
JS JS Pro
Dec 15, 2020 $18.09 -0.28% $18.14 X 99.72% 5
CORealtor CORealtor Merchant
Dec 15, 2020 $17.90 -1.32% $18.14 X 98.68% 1
JS JS Pro
Nov 25, 2020 $17.49 -1.49% $17.76 X 98.51% 1
CORealtor CORealtor Merchant
Nov 25, 2020 $18.00 +1.38% $17.76 X 98.62% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE